Cargando…
Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation
Roxadustat is a new medication for the treatment of renal anemia. EPO (erythropoietin)—the current treatment standard—has been reported to enhance platelet activation and production. However, to date, the effect of roxadustat on platelets is unclear. To address this deficiency, herein, we have evalu...
Autores principales: | Zhao, Jiaxin, Xu, Yanyan, Xie, Jingyuan, Liu, Junling, Zhang, Ruiyan, Yan, Xiaoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454499/ https://www.ncbi.nlm.nih.gov/pubmed/34348487 http://dx.doi.org/10.1161/ATVBAHA.121.316495 |
Ejemplares similares
-
Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma
por: Li, Panpan, et al.
Publicado: (2023) -
Alterations to Sphingomyelin Metabolism Affect Hemostasis and Thrombosis
por: Wang, Jue, et al.
Publicado: (2022) -
NADPH Oxidases Are Required for Full Platelet Activation In Vitro and Thrombosis In Vivo but Dispensable for Plasma Coagulation and Hemostasis
por: Vara, Dina, et al.
Publicado: (2020) -
Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy
por: Hoefer, Thomas, et al.
Publicado: (2015) -
Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets
por: Unsworth, Amanda J., et al.
Publicado: (2017)